FDA Clearance Tracker · P040042-S053
Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension Cable
Last checked: Nov 20, 2026Latest source record: Dec 16, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Dec 16, 2022
Approved
Time to decision
49 days
Received Oct 28, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040042-S053
- Device name
- Safire TX Ablation Catheter, Therapy Dual-8 Ablation Catheter, Safire TX, Catheter Extension Cable
- Applicant
- Irvine Biomedical,Inc.(Ibi)
- Applicant location
- Irvine, CA
- Received
- Oct 28, 2022
- Decided
- Dec 16, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040042
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for Sterigenics Utah as an alternate EO sterilization vendor for Irvine EP cables.
Source documents
Other decisions for Irvine Biomedical,Inc.(Ibi)
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.